Hospital de Sagunto   Report issue

Academic/Hospital Phase 2
Founded: Port de Sagunt Spain

Organization Overview

First Clinical Trial
2005
NCT00415038
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hospital de Sagunto | Hospital de Sagunto - Sagunto (Valencia) - Spain | Hospital de Sagunto, Valencia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Small Cell (Phase 2)

Essential Hypertension (Phase 2)

Hypertension (Phase 2)

Lung Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 5